Rates Rise and Homebuilders Sinks, Plus the MedTech Stock Getting Skinnier, Thanks to the Weight Loss Drug Boom 9/5/23
Homebuilder stocks kick off the week on shaky foundation, as interest rates resume their march higher. What the moves say about the strength of the markets heading into fall. Plus one analyst downgrading shares of ResMed as the boom in weight loss drugs could lead to lower demand for sleep apnea devices. We look at the other side effects of people slimming down and the stocks that could get impacted. Fast Money Disclaimer
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Homebuilder stocks kick off the week on shaky foundation, as interest rates resume their march higher. What the moves say about the strength of the markets heading into fall. Plus one analyst downgrading shares of ResMed as the boom in weight loss drugs could lead to lower demand for sleep apnea devices. We look at the other side effects of people slimming down and the stocks that could get impacted.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.